Elevance Health Inc (ELV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,550,000 | 2,249,000 | 5,991,000 | 5,160,000 | 3,860,000 |
| Depreciation Amortization | 666,000 | 331,000 | 1,745,000 | 1,321,000 | 895,000 |
| Income taxes - deferred | -34,000 | 136,000 | -602,000 | -361,000 | -393,000 |
| Accounts receivable | -1,341,000 | -282,000 | -1,762,000 | -727,000 | -299,000 |
| Accounts payable and accrued liabilities | -1,366,000 | 31,000 | 147,000 | 333,000 | 583,000 |
| Other Working Capital | -2,943,000 | -988,000 | -535,000 | 3,821,000 | 3,611,000 |
| Other Operating Activity | 2,893,000 | 501,000 | 3,077,000 | 1,485,000 | 162,000 |
| Operating Cash Flow | $2,425,000 | $1,978,000 | $8,061,000 | $11,032,000 | $8,419,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -321,000 | -212,000 | 78,000 | 55,000 | 145,000 |
| PPE Investments | -602,000 | -279,000 | -1,296,000 | -970,000 | -651,000 |
| Net Acquisitions | -725,000 | -1,120,000 | -1,552,000 | -1,570,000 | -1,651,000 |
| Purchase Of Investment | -10,035,000 | -6,103,000 | -16,236,000 | -24,337,000 | -17,648,000 |
| Sale Of Investment | 8,620,000 | 5,433,000 | 13,536,000 | 22,361,000 | 15,995,000 |
| Other Investing Activity | -65,000 | -29,000 | -102,000 | -82,000 | -46,000 |
| Investing Cash Flow | $-3,128,000 | $-2,310,000 | $-5,572,000 | $-4,543,000 | $-3,856,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -159,000 | 976,000 | 262,000 | -577,000 | -645,000 |
| Debt Issued | 2,580,000 | N/A | 2,574,000 | 2,574,000 | 2,574,000 |
| Debt Repayment | 0 | 0 | -1,909,000 | -1,908,000 | -1,908,000 |
| Common Stock Issued | 157,000 | 97,000 | 152,000 | 112,000 | 81,000 |
| Common Stock Repurchased | -1,029,000 | -566,000 | -2,676,000 | -1,748,000 | -1,268,000 |
| Dividend Paid | -757,000 | -379,000 | -1,395,000 | -1,049,000 | -701,000 |
| Other Financing Activity | -92,000 | -96,000 | -357,000 | -359,000 | -94,000 |
| Financing Cash Flow | $700,000 | $32,000 | $-3,349,000 | $-2,955,000 | $-1,961,000 |
| Exchange Rate Effect | -5,000 | N/A | -1,000 | -2,000 | 2,000 |
| Beginning Cash Position | 6,505,000 | 6,526,000 | 7,387,000 | 7,387,000 | 7,387,000 |
| End Cash Position | 6,497,000 | 6,226,000 | 6,526,000 | 10,919,000 | 9,991,000 |
| Net Cash Flow | $-8,000 | $-300,000 | $-861,000 | $3,532,000 | $2,604,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,425,000 | 1,978,000 | 8,061,000 | 11,032,000 | 8,419,000 |
| Capital Expenditure | -602,000 | -279,000 | -1,296,000 | -970,000 | -651,000 |
| Free Cash Flow | 1,823,000 | 1,699,000 | 6,765,000 | 10,062,000 | 7,768,000 |